Specialty Pharmaceutical Company dedicated to patients living with chronic pain

Filing date Description Form Filing Group Filer View

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0000899243-19-002529.pdf 0000899243-19-002529.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-002533.pdf 0000899243-19-002533.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Vollins James 0000899243-19-002535.pdf 0000899243-19-002535.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-021047.pdf 0001193125-19-021047.rtf 0001193125-19-021047.xls View HTML

Pre-effective amendment to an S-3 filing

S-3/A
Registration Statements
0001193125-19-012975.pdf 0001193125-19-012975.rtf 0001193125-19-012975.xls View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Coelho Mary Theresa 0000899243-19-001535.pdf 0000899243-19-001535.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Coelho Mary Theresa 0000899243-19-001537.pdf 0000899243-19-001537.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-011574.pdf 0001193125-19-011574.rtf 0001193125-19-011574.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-000560.pdf 0000899243-19-000560.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-000559.pdf 0000899243-19-000559.rtf View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon